Background illustration for clinical trials search

Paid Clinical Trials District of Columbia

Discover 774 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Advancing Transplantation Outcomes in Children

for
Kidney Transplant
Location: Boston MA, Philadelphia PA, Wilmington DE, Baltimore MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 13 - 20

Code: NCT06055608

Phase 2, Recruiting
Active & Responsive

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

for
HER2-positive Metastatic Breast Cancer
Location: Westerly RI, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT06551116

Recruiting
Active & Responsive

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Halifax, Boston MA, New Haven CT, Queens NY,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 21

Code: NCT05183035

Phase 3, Recruiting
Active & Responsive

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07277413

Phase 1, Recruiting
Active & Responsive

Family Intervention for Black Teens With Type 1 Diabetes

for
Type 1 Diabetes, Family Relations
Location: Washington D.C. DC, Detroit MI, Memphis TN
Sponsor: Wayne State University

Sex: All

Age: 10 - 14

Code: NCT06275412

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors

for
Solid Tumor, KRAS Mutation-Related Tumors
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT05661201

Phase 1, Recruiting
Active & Responsive

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

for
Diffuse Midline Glioma (DMG), Glioblastoma,
Location: Philadelphia PA, Washington D.C. DC, Atlanta GA,
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 2 - 21

Code: NCT04732065

Phase 1, Recruiting
Active & Responsive

SNS and PrEP Initiation and Adherence in Black SMM

for
HIV
Location: Washington DC
Sponsor: Us Helping Us, People Into Living, Inc.

Sex: Male

Age: 18+

Code: NCT05499962

Recruiting
Active & Responsive

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Boston MA, Staten Island NY, New York NY, Newark NJ,
Sponsor: Endologix

Sex: All

Age: 21+

Code: NCT05064540

Recruiting
Active & Responsive

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

for
Breast Cancer Stage I, Breast Cancer Stage II,
Location: Washington D.C. DC
Sponsor: George Washington University

Sex: All

Age: 21+

Code: NCT06806930

Phase 2, Recruiting
Active & Responsive

BBD Longitudinal Study of Osteogenesis Imperfecta

for
Osteogenesis Imperfecta
Location: New York NY, Montreal, Wilmington DE, Baltimore MD,
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT02432625

Recruiting
Active & Responsive

Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block

for
Heart Block Complete, Heart Block Second Degree
Location: Halifax, Boston MA, New York NY, Washington DC, Toronto,
Sponsor: The Hospital for Sick Children

Sex: Female

Age: 16 - 50

Code: NCT04559425

Recruiting
Active & Responsive

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

for
Mesial Temporal Lobe Epilepsy
Location: Boston MA, Lebanon NH, Great Neck NY, New York NY,
Sponsor: Neurona Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05135091

Phase 3, Recruiting
Active & Responsive

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

for
End Stage Renal Disease
Location: Washington DC, Charlotte NC, Cincinnati OH,
Sponsor: Rockwell Medical Technologies, Inc.

Sex: All

Age: 0 - 17

Code: NCT04239391

Phase 3, Recruiting
Active & Responsive

A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

for
Chondral Defect, Articular Cartilage Defect
Location: Washington D.C. DC, Charlottesville VA, Durham NC,
Sponsor: Vericel Corporation

Sex: All

Age: 17 - 65

Code: NCT06915233

Phase 3, Recruiting
Active & Responsive

Plant-Based Online Weight Loss Through Education and Resources Program and Study

for
Type 2 Diabetes, Overweight and Obese Adults
Location: Washington D.C. DC
Sponsor: Physicians Committee for Responsible Medicine

Sex: All

Age: 18+

Code: NCT07095543

Recruiting
Active & Responsive

Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

for
Myasthenia Gravis (MG)
Location: Washington D.C. DC
Sponsor: George Washington University

Sex: All

Age: 18+

Code: NCT07787247

Recruiting
Active & Responsive

A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

for
Phelan-McDermid Syndrome
Location: Brookline MA, Lexington MA, New York NY,
Sponsor: Neuren Pharmaceuticals Limited

Sex: All

Age: 3 - 12

Code: NCT07281079

Phase 3, Recruiting
Active & Responsive

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

for
Malignant Peripheral Nerve Sheath Tumor (MPNST),
Location: Washington D.C. DC, Dallas TX
Sponsor: AeRang Kim

Sex: All

Age: 18+

Code: NCT06735820

Phase 1, Phase 2, Recruiting
Active & Responsive

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

for
Advanced Breast Cancer, Early Breast Cancer
Location: Westbury NY, The Bronx NY, New York NY, Amsterdam NY,
Sponsor: TerSera Therapeutics LLC

Sex: Female

Age: 18 - 55

Code: NCT07310420

Phase 1, Recruiting

Popular cities in District of Columbia

Washington, D.C.